SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

STRIDES PHARMA SCIENCE

BSE: 532531 29 Jun 2025
Healthcare
₹ 829.2
STRIDES PHARMA SCIENCE LIMITED specializes in Pharmaceuticals within the Healthcare sector.

STRIDES PHARMA SCIENCE - Share Price & Details

Market Cap
₹8,283
High /Low
908.0 / 422.0
Stock P/E
23.4
Book Value
₹277.0
Dividend Yield
0.28
ROCE
14.8
ROE
₹15.2
Face Value
10.0
PEG Ratio
0.68
EVEBITDA
₹11.6
Debt
1,880
CMP / FCF
21.8
Debt to equity
₹0.74
NP Ann
3,598
High price all time
908.0
Piotroski score
₹8.0
Graham Number
1,558
No. Eq. Shares
9.22
Net CF
₹-47.9
Net profit
3,598
Price to book value
3.25
Interest Coverage
₹2.7
Low price all time
26.0
Industry PE
32.7
Reserves
₹2,460
Free Cash Flow
₹510

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
STRIDES PHARMA SCIENCE LIMITED5680.8161.285559.581.758,28323.4
FDC LTD.NANANANA780929.3
Aarti Pharmalabs Limited5271.19888.455296.249.8773328.4

Peer Comparison Chart


About STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE LIMITED, with Security Code 532531, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Market Trading Guide: Lupin, Mastek are among 5 stocks to buy on Thursday. Potential upside up to 7%

(11 Jun 2025)
Target: Rs 905Stop loss: Rs 849Strides Pharma Science (STAR) has broken above its recent swing high and is currently trading in a Higher...
Read more →

Buy Tata Motors, Blue Star & Strides Pharma shares, suggest Rajesh Palviya of Axis Securities

(11 Jun 2025)
An analyst from Axis Securities said that Tata Motors has experienced a trend reversal on the daily and weekly time frame, forming a series...
Read more →

Has Strides Pharma declared dividend?

(07 Jun 2025)
Strides Pharma Science Ltd has declared a 25% dividend, amounting to ₹2.5 per share, with an ex-date of September 9, 2024.
Read more →

Strides Pharma Science: Senior Vice President - Treasury Ramesh RJ supperannuates

(05 Jun 2025)
Mumbai: Strides Pharma Science Limited has announced that Ramesh RJ, Senior Vice President - Treasury, one of the Senior Management...
Read more →

Strides Pharma Q4 net profit rises 5x to Rs. 113 Cr

(24 May 2025)
Strides Pharma Science announced its consolidated financial results for the quarter (Q4FY25) and full year (FY25) ended March 31, 2025.
Read more →

Strides Pharma outperforms guidance of 12–15%, aided by strong US business performance in Q4

(23 May 2025)
Strides Pharma Science Ltd. reported a net profit of ₹85.6 crore, compared to a profit of ₹10.4 crore on a year-on-year basis.
Read more →